Global Allopurinol Tablets Market Size to Worth USD 1.92 Billion by 2033 | CAGR of 6.63%
Category: HealthcareGlobal Allopurinol Tablets Market Size to Worth USD 1.92 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Allopurinol Tablets Market Size is expected to Grow from USD 1.01 Billion in 2023 to USD 1.92 Billion by 2033, at a CAGR of 6.63% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 Market data tables and figures & charts from the report on the "Global Allopurinol Tablets Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Capsules, Tablets, and Others), By Dose (100mg, 300mg, and Others), By Indications (Kidney Stones, Gout, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/allopurinol-tablets-market
The allopurinol tablets market is a pharmaceutical industry sector that develops, formulates, and commercializes tablets used for managing gout and hyperuricemia. Allopurinol is a xanthine oxidase inhibitor that prevents the conversion of hypoxanthine and xanthine to uric acid, a substance commonly used to treat hyperuricemia, high uric acid levels, cancer medicines, kidney stones, and gout. It works by decreasing the body's production of uric acid, which can lead to joint pain and inflammation. Various products of allopurinol include Zyloprim, Zylowell, AllopurCare, and Apllinol. The rising prevalence of gout, an inflammatory arthritis causing severe joint pain and swelling, has led to increased demand for gout therapeutics like allopurinol tablets. The market growth is driven by the focus on novel drug delivery systems, such as allopurinol-loaded chitosan-coated magnetic nanoparticles (A-MNPs), which show promise in treating hyperuricemic kidney stones. Researchers are also exploring combining allopurinol with other urate-lowering treatments to increase effectiveness and reduce side effects, particularly for individuals with refractory gout. However, rigorous government guidelines may restrain the growth of the market.
The tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the dosage form, the global allopurinol tablets market is categorized as capsules, tablets, and others. Among these, the tablets segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is driven by stability, accurate dosing, patient compliance, ease of administration, and availability of controlled tablets. These tablets offer better disintegration time, faster action, longer shelf life, and reduced microbial contamination risk due to water absence.
The 100mg segment accounted for a substantial share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the dose, the global allopurinol tablets market is categorized as 100mg, 300mg, and others. Among these, the 100mg segment accounted for a substantial share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is ascribed to allopurinol 100 mg tablets are the first-line treatment for gout patients, have a low risk of side effects, and are practical for both adult and elderly populations.
The gout segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the indications, the global allopurinol tablets market is categorized as kidney stones, gout, and others. Among these, the gout segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The growth of the segment is attributed to the rise in gout prevalence, consumption of purine-rich food, and the use of allopurinol as a first-line treatment.
The hospital pharmacies segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global allopurinol tablets market is categorized as retail pharmacies, online pharmacies, hospital pharmacies, and others. Among these, the hospital pharmacies segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The sector's growth is attributed to the availability of allopurinol tablets, cost-effectiveness, compounding facilities, blood profile monitoring, collaborations between hospitals, and personalized medications.
North America is expected to hold the greatest share of the global allopurinol tablets market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global allopurinol tablets market over the forecast period. This is attributed to high kidney stones and gout incidence, established healthcare systems, and chronic disease management. Evidence-based treatment options are adopted, and facilitated by vendors and research activities. Rising healthcare spending and favorable laws make drug approval and commercialization easier.
Asia Pacific is predicted to grow at the fastest CAGR rate throughout the estimated period. The Asia Pacific market for allopurinol is expanding due to increased healthcare awareness, improved infrastructure, and a large patient base. China and India are experiencing rapid growth due to urbanization, lifestyle changes, and government programs. The aging population and increased prevalence of kidney stones and gout require allopurinol therapy.
Major key players in the global allopurinol tablets market are Zydus Cadila, Mylan N. V., Jubilant Generics Limited, Apotex Inc., GlaxoSmithKline, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Limited, Amneal Pharmaceuticals LLC, Cipla Limited, Hetero Drugs Ltd., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In April 2024, Camber Pharmaceuticals announced the introduction of the Allopurinol Tablets to its product portfolio. Allopurinol is used in the management of the signs and symptoms of primary and secondary gout and acts as an Anti-Hyperuricemic medication.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global allopurinol tablets market based on the below-mentioned segments:
Global Allopurinol Tablets Market, By Dosage Form
- Capsules
- Tablets
- Others
Global Allopurinol Tablets Market, By Dose
- 100mg
- 300mg
- Others
Global Allopurinol Tablets Market, By Indications
- Kidney Stones
- Gout
- Others
Global Allopurinol Tablets Market, By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
- Others
Global Allopurinol Tablets Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?